TFAP2C Knockdown Sensitizes Bladder Cancer Cells to Cisplatin Treatment via Regulation of EGFR and NF-κB.
Xing J, Chen W, Chen K, Zhu S, Lin F, Qi Y, Zhang Y, Han S, Rao T, Ruan Y, Zhao S, Yu W, Cheng F.
Xing J, et al. Among authors: chen k, chen w.
Cancers (Basel). 2022 Sep 30;14(19):4809. doi: 10.3390/cancers14194809.
Cancers (Basel). 2022.
PMID: 36230734
Free PMC article.